Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia
Author(s) -
Hana Hakim,
Ronald H. Dallas,
Joshua Wolf,
Li Tang,
Stacey SchultzCherry,
Victoria R Darling,
Cydney N. Johnson,
Erik A. Karlsson,
TiCheng Chang,
Sima Jeha,
ChingHon Pui,
Yilun Sun,
Stanley Pounds,
Randall T. Hayden,
Elaine Tuomanen,
Jason W. Rosch
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy153
Subject(s) - microbiome , medicine , chemotherapy , streptococcaceae , febrile neutropenia , immunology , neutropenia , biology , antibiotics , microbiology and biotechnology , bioinformatics
Myelosuppression-related infections remain important causes of morbidity and mortality in children with acute lymphoblastic leukemia (ALL).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom